腫瘍生物学・免疫学および全身療法(免疫療法・分子標的療法)に関する査読付き論文を40本以上執筆し、トルコ腫瘍内科学会およびEuropean Head & Neck Societyの会員である。
患者がビュレント・カラゴズ医師を選ぶ理由:
アナドル医療センターにおける卵巣癌化学療法を専門とするタンルクル医師は、トルコトップクラスの腫瘍専門医の一人です。
ヒサル・ホスピタル・インターコンチネンタルにて卵巣癌を専門とし、ハジェテペ大学癌研究所およびMDアンダーソン癌センターにて研鑽を積む。
Patients traveling to Turkey for ovarian cancer chemotherapy must present a valid passport, a medical visa or e-visa, and an official hospital invitation letter. Essential medical records include original pathology reports, DICOM-compatible imaging scans, and recent genetic testing results like BRCA1 or BRCA2 mutations to guide treatment protocols.
Bookimed Expert Insight: Clinics like Anadolu Medical Center follow strict American treatment standards through Johns Hopkins Medicine affiliations. This means your home records must be highly detailed. Translating your pathology reports into Turkish or English before arrival can save you up to 500 USD in local urgent translation fees.
Patient Consensus: Many suggest emailing digital scans to your clinic 2 weeks early. Bringing a 2-week supply of current medications helps avoid gaps while local prescriptions are processed.
Anadolu Medical Center, Memorial Healthcare Group, and Acibadem Healthcare provide leading ovarian cancer chemotherapy in Turkey through international protocols. These JCI-accredited centers offer advanced systemic treatments, including targeted therapies and HIPEC, often through strategic collaborations with top-tier global institutions like Johns Hopkins Medicine.
Bookimed Expert Insight: Anadolu Medical Center stands out because its oncologists, like Dr. Bulent Karagoz, follow strict U.S. treatment protocols via their Johns Hopkins partnership. This provides patients with access to Western-level clinical standards at Turkish price points, which typically start around $2,700 per cycle.
Patient Consensus: Patients recommend shipping pathology slides to Turkey in advance to fast-track personalized treatment plans. Many highlight the affordability of combining PARP inhibitors with standard chemotherapy compared to costs in the US or Europe.